Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Royalty Pharma plc RPRX

Full chart Compare
Set alert

Price alert · RPRX

All alert types
66.92 USD +0.52 (+0.78%)

Nov 4, 2026, 2:08 PM EST

64.84 Day range 67.18
37.84 52-week range 67.18
YTD
+73.18%
1 year
+76.84%

Financial health

Altman Z-Score

2.37 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 4
  • Return on Equity 4
  • Return on Assets 4
  • Debt / Equity 1
  • P/E 2
  • P/B 2

Valuation

P/E 16.6×
FY 2016: 47.8×FY 2017: 13.0×FY 2018: 11.4×FY 2019: 6.7×FY 2020: 39.1×FY 2021: 26.7×FY 2022: 404×FY 2023: 8.2×FY 2024: 13.3×FY 2025: 16.6×
FY 2016 5y median 16.6× FY 2025
P/S 7.0×
FY 2016: 14.4×FY 2017: 9.9×FY 2018: 8.8×FY 2019: 8.7×FY 2020: 9.2×FY 2021: 7.2×FY 2022: 7.7×FY 2023: 5.3×FY 2024: 5.0×FY 2025: 7.0×
FY 2016 5y median 7.0× FY 2025
P/B 2.6×
FY 2016: 6.1×FY 2017: 3.5×FY 2018: 3.5×FY 2019: 2.6×FY 2020: 4.0×FY 2021: 2.9×FY 2022: 3.1×FY 2023: 1.9×FY 2024: 1.6×FY 2025: 2.6×
FY 2016 5y median 2.6× FY 2025
P/FCF 6.7×
FY 2016: 0.0×FY 2017: 11.1×FY 2018: 9.7×FY 2019: 9.5×FY 2020: 9.5×FY 2021: 8.2×FY 2022: 8.1×FY 2023: 4.2×FY 2024: 4.1×FY 2025: 6.7×
FY 2016 5y median 6.7× FY 2025
EV/EBITDA 15.3×
FY 2016: 29.2×FY 2017: 13.0×FY 2018: 11.1×FY 2019: 7.9×FY 2020: 12.9×FY 2021: 15.4×FY 2022: 53.6×FY 2023: 9.7×FY 2024: 11.6×FY 2025: 15.3×
FY 2016 5y median 15.3× FY 2025
EV/Sales 10.5×
FY 2016: 16.6×FY 2017: 13.3×FY 2018: 11.3×FY 2019: 12.0×FY 2020: 11.4×FY 2021: 9.6×FY 2022: 10.2×FY 2023: 7.7×FY 2024: 8.0×FY 2025: 10.5×
FY 2016 5y median 9.6× FY 2025
FCF Yield 14.9%
FY 2016: 0.0%FY 2017: 9.0%FY 2018: 10.3%FY 2019: 10.6%FY 2020: 10.5%FY 2021: 12.2%FY 2022: 12.4%FY 2023: 23.8%FY 2024: 24.3%FY 2025: 14.9%
FY 2016 5y median 14.9% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin 65.6%
FY 2016: 38.5%FY 2017: 58.8%FY 2018: 76.0%FY 2019: 144.6%FY 2020: 75.2%FY 2021: 62.5%FY 2022: 13.7%FY 2023: 63.4%FY 2024: 57.1%FY 2025: 65.6%
FY 2016 5y median 62.5% FY 2025
Net Margin 32.4%
FY 2016: 30.1%FY 2017: 75.7%FY 2018: 76.8%FY 2019: 129.4%FY 2020: 45.9%FY 2021: 27.1%FY 2022: 1.9%FY 2023: 48.2%FY 2024: 37.9%FY 2025: 32.4%
FY 2016 5y median 32.4% FY 2025
ROE 11.9%
FY 2016: 12.7%FY 2017: 27.1%FY 2018: 30.7%FY 2019: 38.5%FY 2020: 20.2%FY 2021: 10.7%FY 2022: 0.8%FY 2023: 17.4%FY 2024: 12.4%FY 2025: 11.9%
FY 2016 5y median 11.9% FY 2025
ROIC 8.9%
FY 2016: 7.0%FY 2017: 8.3%FY 2018: 12.3%FY 2019: 21.2%FY 2020: 10.2%FY 2021: 8.2%FY 2022: 1.8%FY 2023: 9.2%FY 2024: 7.2%FY 2025: 8.9%
FY 2016 5y median 8.2% FY 2025
ROA 3.9%
FY 2016: 5.4%FY 2017: 10.6%FY 2018: 12.1%FY 2019: 18.9%FY 2020: 6.1%FY 2021: 3.5%FY 2022: 0.3%FY 2023: 6.9%FY 2024: 4.7%FY 2025: 3.9%
FY 2016 5y median 3.9% FY 2025

Growth (YoY)

Revenue 5.1%
FY 2016: 13.6%FY 2017: -14.9%FY 2018: 12.3%FY 2019: 1.1%FY 2020: 17.0%FY 2021: 7.9%FY 2022: -2.3%FY 2023: 5.2%FY 2024: -3.9%FY 2025: 5.1%
FY 2016 FY 2025
Operating Income 20.7%
FY 2016: -9.0%FY 2017: 30.0%FY 2018: 45.2%FY 2019: 92.3%FY 2020: -39.2%FY 2021: -10.3%FY 2022: -78.5%FY 2023: 385.9%FY 2024: -13.4%FY 2025: 20.7%
FY 2016 FY 2025
EPS (diluted) -5.8%
FY 2016: -3.1%FY 2017: 267.7%FY 2018: 13.7%FY 2019: 70.4%FY 2020: -80.7%FY 2021: 16.4%FY 2022: -93.3%FY 2023: 2430.0%FY 2024: -24.5%FY 2025: -5.8%
FY 2016 FY 2025
Free Cash Flow -10.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 14.1%FY 2019: 3.0%FY 2020: 22.0%FY 2021: -0.8%FY 2022: 6.3%FY 2023: 39.4%FY 2024: -7.3%FY 2025: -10.1%
FY 2016 FY 2025

Financial Health

Current Ratio 1.0×
FY 2016: 10.1×FY 2017: 7.7×FY 2018: 4.5×FY 2019: 2.5×FY 2020: 8.8×FY 2021: 16.8×FY 2022: 2.2×FY 2023: 7.9×FY 2024: 1.4×FY 2025: 1.0×
FY 2016 5y median 2.2× FY 2025
Quick Ratio 1.0×
FY 2016: 10.1×FY 2017: 7.7×FY 2018: 4.5×FY 2019: 2.5×FY 2020: 8.8×FY 2021: 16.8×FY 2022: 2.2×FY 2023: 7.9×FY 2024: 1.4×FY 2025: 1.0×
FY 2016 5y median 2.2× FY 2025
Debt / Equity 1.4×
FY 2016: 1.3×FY 2017: 1.5×FY 2018: 1.5×FY 2019: 1.0×FY 2020: 1.2×FY 2021: 1.2×FY 2022: 1.3×FY 2023: 0.9×FY 2024: 1.1×FY 2025: 1.4×
FY 2016 5y median 1.2× FY 2025
Net Debt / EBITDA 5.1×
FY 2016: 4.0×FY 2017: 3.3×FY 2018: 2.5×FY 2019: 2.2×FY 2020: 2.6×FY 2021: 3.9×FY 2022: 12.8×FY 2023: 3.0×FY 2024: 4.3×FY 2025: 5.1×
FY 2016 5y median 4.3× FY 2025
Interest Coverage 5.1×
FY 2016: 3.0×FY 2017: 3.8×FY 2018: 4.9×FY 2019: 9.8×FY 2020: 10.2×FY 2021: 8.6×FY 2022: 1.6×FY 2023: 8.0×FY 2024: 5.7×FY 2025: 5.1×
FY 2016 5y median 5.7× FY 2025

Dividends

Dividend Yield 2.3%
FY 2016: 0.0%FY 2017: 4.7%FY 2018: 5.2%FY 2019: 4.7%FY 2020: 2.0%FY 2021: 1.7%FY 2022: 1.9%FY 2023: 2.8%FY 2024: 3.3%FY 2025: 2.3%
FY 2016 5y median 2.3% FY 2025
Payout Ratio 49.1%
FY 2016: 0.0%FY 2017: 60.8%FY 2018: 59.1%FY 2019: 31.5%FY 2020: 40.8%FY 2021: 46.0%FY 2022: 778.2%FY 2023: 31.6%FY 2024: 43.8%FY 2025: 49.1%
FY 2016 5y median 46.0% FY 2025

Annual · latest fiscal year ends 2025-12-31